Aberdeen Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.1M | Sell |
167,222
-87
| -0.1% | -$7.98K | 0.02% | 494 |
|
|
2025
Q4 | $15M | Sell |
167,309
-6,740
| -4% | -$639K | 0.02% | 511 |
|
|
2025
Q3 | $17.1M | Buy |
174,049
+1,611
| +0.9% | +$160K | 0.03% | 480 |
|
|
2025
Q2 | $15.7M | Buy |
172,438
+15,536
| +10% | +$1.5M | 0.03% | 480 |
|
|
2025
Q1 | $17.6M | Sell |
156,902
-213,381
| -58% | -$22.8M | 0.03% | 424 |
|
|
2024
Q4 | $39M | Buy |
370,283
+1,982
| +0.5% | +$213K | 0.07% | 244 |
|
|
2024
Q3 | $39.6M | Sell |
368,301
-85,169
| -19% | -$9.3M | 0.07% | 250 |
|
|
2024
Q2 | $49.2M | Buy |
453,470
+12,154
| +3% | +$1.43M | 0.09% | 206 |
|
|
2024
Q1 | $58.2M | Buy |
441,316
+20,723
| +5% | +$2.59M | 0.11% | 189 |
|
|
2023
Q4 | $51.2M | Buy |
420,593
+147,606
| +54% | +$16.5M | 0.11% | 200 |
|
|
2023
Q3 | $30.6M | Buy |
272,987
+69,739
| +34% | +$8.86M | 0.08% | 230 |
|
|
2023
Q2 | $29.6M | Buy |
203,248
+141,033
| +227% | +$19.2M | 0.07% | 266 |
|
|
2023
Q1 | $8.04M | Buy |
62,215
+8,028
| +15% | +$1.01M | 0.02% | 506 |
|
|
2022
Q4 | $6.91M | Buy |
54,187
+4,050
| +8% | +$470K | 0.02% | 508 |
|
|
2022
Q3 | $5.24M | Sell |
50,137
-523
| -1% | -$57.4K | 0.02% | 545 |
|
|
2022
Q2 | $5.38M | Sell |
50,660
-1,004
| -2% | -$119K | 0.02% | 535 |
|
|
2022
Q1 | $6.69M | Sell |
51,664
-20,995
| -29% | -$2.53M | 0.02% | 527 |
|
|
2021
Q4 | $8.96M | Sell |
72,659
-3,851
| -5% | -$504K | 0.02% | 512 |
|
|
2021
Q3 | $11M | Sell |
76,510
-6,090
| -7% | -$896K | 0.02% | 475 |
|
|
2021
Q2 | $12.9M | Sell |
82,600
-3,228
| -4% | -$523K | 0.03% | 447 |
|
|
2021
Q1 | $13.3M | Buy |
85,828
+5,845
| +7% | +$905K | 0.03% | 435 |
|
|
2020
Q4 | $12M | Buy |
79,983
+3,271
| +4% | +$462K | 0.03% | 426 |
|
|
2020
Q3 | $10.1M | Sell |
76,712
-11,159
| -13% | -$1.46M | 0.03% | 428 |
|
|
2020
Q2 | $10.2M | Sell |
87,871
-5,688
| -6% | -$655K | 0.03% | 412 |
|
|
2020
Q1 | $9.19M | Buy |
93,559
+1,256
| +1% | +$165K | 0.03% | 402 |
|
|
2019
Q4 | $13.4M | Sell |
92,303
-2,136
| -2% | -$295K | 0.03% | 401 |
|
|
2019
Q3 | $12.6M | Sell |
94,439
-59,722
| -39% | -$7.71M | 0.03% | 402 |
|
|
2019
Q2 | $17.6M | Sell |
154,161
-2,604
| -2% | -$305K | 0.04% | 383 |
|
|
2019
Q1 | $19.4M | Buy |
156,765
+52,095
| +50% | +$5.92M | 0.04% | 364 |
|
|
2018
Q4 | $10.3M | Buy |
104,670
+394
| +0.4% | +$44.3K | 0.02% | 441 |
|
|
2018
Q3 | $13.3M | Buy |
104,276
+4,859
| +5% | +$578K | 0.02% | 451 |
|
|
2018
Q2 | $10.8M | Buy |
99,417
+11,338
| +13% | +$1.23M | 0.02% | 465 |
|
|
2018
Q1 | $9.32M | Buy |
88,079
+9,723
| +12% | +$1.13M | 0.02% | 459 |
|
|
2017
Q4 | $9.18M | Buy |
78,356
+28,760
| +58% | +$3.25M | 0.02% | 465 |
|
|
2017
Q3 | $5.64M | Buy |
+49,596
| New | +$5.73M | 0.01% | 530 |
|
Other funds holding ZBH
VCM
VPM
Aberdeen Group's ZBH Position: Q1 2026 in Review
Aberdeen Group reduced its Zimmer Biomet (ZBH) stake by 0.05% in Q1 2026, selling an estimated $7.98K and leaving 167,222 shares worth $15.1M. The position accounts for 0.02% of the portfolio, ranked #494.
Aberdeen Group first reported a position in ZBH in Q3 2017 and has held it in 35 quarters since. The position peaked at $58.2M in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Aberdeen Group held 167,222 shares of Zimmer Biomet worth $15.1M as of Q1 2026.
- Aberdeen Group sold 87 Zimmer Biomet shares in Q1 2026, an estimated $7.98K.
- Zimmer Biomet made up 0.02% of Aberdeen Group's portfolio in Q1 2026, its #494 holding.
- Aberdeen Group first reported a position in Zimmer Biomet in Q3 2017 and has held it in 35 quarters since.
- Aberdeen Group's Zimmer Biomet position peaked at $58.2M in Q1 2024.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.